4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane
ALDRICH/291110 - 98%
Synonym: Cryptand 222; Kryptofix® 222
CAS Number: 23978-09-8
Empirical Formula (Hill Notation): C18H36N2O6
Molecular Weight: 376.49
EC Number: 245-962-4
MDL Number: MFCD00005111
Linear Formula: C18H36N2O6
Product Type: Chemical
| assay | 98% |
| form | solid |
| InChI | 1S/C18H36N2O6/c1-7-21-13- |
| InChI key | AUFVJZSDSXXFOI-UHFFFAOYSA |
| mp | 68-71 °C (lit.) |
| Quality Level | 200 ![]() |
| SMILES string | C1COCCN2CCOCCOCCN(CCO1)CC |
| Application: | 4,7,13,16,21,24-Hexaoxa-1 • A electrolyte additive in isotachophoresis[separati • A complexing agent in the preparation of K+-imprinted nanoparticles using methacrylic acid as the functional monomer, ethylene glycol dimethacrylate as the crosslinker and 2,2′-azobisisobutyronitri • A structure directing agent (SDA) in the preparation of LTA-type AlPO4 crystals. |
| General description: | 4,7,13,16,21,24-Hexaoxa-1 |
| Legal Information: | Kryptofix is a registered trademark of Merck KGaA, Darmstadt, Germany |
| Packaging: | 1 g in glass bottle |
| Packaging: | 250 mg in glass bottle |
| Packaging: | Bottomless glass bottle. Contents are inside inserted fused cone. |
| Packaging: | Cryptand used with potassium mirror to reduce a hindered distannene to a crystalline radical anion. |
| Symbol | ![]() GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302 - H315 - H318 |
| Precautionary statements | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | 98% |
| mp | 68-71 °C (lit.) |
| UNSPSC | 12352005 |



